Related Experiment Video
Updated: Sep 22, 2025

08:50
Prostaglandin Extraction and Analysis in Caenorhabditis elegans
Published on: June 25, 2013
19.7K
PPAR-gamma Fun(gi) With Prostaglandin
Robert J Evans1, Simon A Johnston2
1The Francis Crick Institute, London, UK.
Nuclear Receptor Signaling
|May 18, 2022
Summary
The fungus Cryptococcus neoformans mimics host eicosanoids to manipulate immune cells. It activates the PPAR-gamma receptor, impacting macrophage inflammation.
Area of Science:
- Immunology
- Mycology
- Molecular Biology
Background:
- * Cryptococcus neoformans is a fungal pathogen that causes cryptococcosis.
- * Host immune responses are crucial for controlling fungal infections.
- * Eicosanoids are signaling molecules involved in inflammation and immune regulation.
Purpose of the Study:
- * To investigate the mechanism by which Cryptococcus neoformans manipulates host cells.
- * To identify the specific molecules produced by the fungus that mediate this manipulation.
- * To understand how these fungal molecules affect host innate immune cells.
Main Methods:
- * In vivo infection model using zebrafish.
- * In vitro macrophage cell culture model.
- * Analysis of eicosanoid production and host receptor activation.
Main Results:
- * Cryptococcus neoformans produces eicosanoids that mimic host molecules.
- * These fungal eicosanoids activate the host receptor PPAR-gamma.
- * 15-keto-PGE2 was identified as the key eicosanoid, acting as a partial agonist to PPAR-gamma.
Conclusions:
- * Fungal eicosanoids are a novel mechanism for immune evasion by Cryptococcus neoformans.
- * Activation of PPAR-gamma by fungal eicosanoids modulates macrophage inflammatory responses.
- * This study opens new avenues for therapeutic strategies targeting fungal manipulation of host immunity.
Keywords:
15-keto-PGE2Cryptococcus neoformansPPAR-gammaeicosanoidsfungal infectionhost pathogen interactionsmacrophageszebrafishMore Related Videos
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
6.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.0K
IP3/DAG Signaling Pathway
12.6K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
263
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
263
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
614
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
614
GPCR Desensitization
6.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.6K
G-protein Coupled Receptors
121.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.9K

